Balchem Retained Earnings (Accumulated Deficit) 2010-2024 | BCPC
Balchem retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Balchem retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $0.992B, a 10.71% increase year-over-year.
- Balchem retained earnings (accumulated deficit) for 2023 were $0.897B, a 10.19% increase from 2022.
- Balchem retained earnings (accumulated deficit) for 2022 were $0.814B, a 11.25% increase from 2021.
- Balchem retained earnings (accumulated deficit) for 2021 were $0.732B, a 11.48% increase from 2020.
Balchem Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2023 |
$897 |
| 2022 |
$814 |
| 2021 |
$732 |
| 2020 |
$657 |
| 2019 |
$591 |
| 2018 |
$528 |
| 2017 |
$465 |
| 2016 |
$388 |
| 2015 |
$344 |
| 2014 |
$295 |
| 2013 |
$252 |
| 2012 |
$215 |
| 2011 |
$181 |
| 2010 |
$148 |
| 2009 |
$119 |
Balchem Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024-09-30 |
$992 |
| 2024-06-30 |
$959 |
| 2024-03-31 |
$926 |
| 2023-12-31 |
$897 |
| 2023-09-30 |
$896 |
| 2023-06-30 |
$867 |
| 2023-03-31 |
$837 |
| 2022-12-31 |
$814 |
| 2022-09-30 |
$816 |
| 2022-06-30 |
$791 |
| 2022-03-31 |
$761 |
| 2021-12-31 |
$732 |
| 2021-09-30 |
$728 |
| 2021-06-30 |
$703 |
| 2021-03-31 |
$680 |
| 2020-12-31 |
$657 |
| 2020-09-30 |
$653 |
| 2020-06-30 |
$632 |
| 2020-03-31 |
$611 |
| 2019-12-31 |
$591 |
| 2019-09-30 |
$587 |
| 2019-06-30 |
$567 |
| 2019-03-31 |
$547 |
| 2018-12-31 |
$528 |
| 2018-09-30 |
$523 |
| 2018-06-30 |
$504 |
| 2018-03-31 |
$484 |
| 2017-12-31 |
$465 |
| 2017-09-30 |
$436 |
| 2017-06-30 |
$420 |
| 2017-03-31 |
$404 |
| 2016-12-31 |
$388 |
| 2016-09-30 |
$384 |
| 2016-06-30 |
$370 |
| 2016-03-31 |
$356 |
| 2015-12-31 |
$344 |
| 2015-09-30 |
$339 |
| 2015-06-30 |
$325 |
| 2015-03-31 |
$310 |
| 2014-12-31 |
$295 |
| 2014-09-30 |
$285 |
| 2014-06-30 |
$270 |
| 2014-03-31 |
$261 |
| 2013-12-31 |
$252 |
| 2013-09-30 |
$249 |
| 2013-06-30 |
$237 |
| 2013-03-31 |
$226 |
| 2012-12-31 |
$215 |
| 2012-09-30 |
$211 |
| 2012-06-30 |
$200 |
| 2012-03-31 |
$190 |
| 2011-12-31 |
$181 |
| 2011-09-30 |
$177 |
| 2011-06-30 |
$166 |
| 2011-03-31 |
$156 |
| 2010-12-31 |
$148 |
| 2010-09-30 |
$142 |
| 2010-06-30 |
$134 |
| 2010-03-31 |
$126 |
| 2009-12-31 |
$119 |
| 2009-09-30 |
$115 |
| 2009-06-30 |
$108 |
| 2009-03-31 |
$101 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Specialty |
$5.574B |
$0.922B |
|
Balchem Corporation provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. Balchem Company consists of four business segments: Human Nutrition & Health; Animal Nutrition & Health; Specialty Products; and Industrial Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. The Industrial Products segment manufactures and supplies certain derivative products into industrial applications.
|
